These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 22846996)
1. The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies. Palakodeti A; Sandstrom A; Sundaresan L; Harly C; Nedellec S; Olive D; Scotet E; Bonneville M; Adams EJ J Biol Chem; 2012 Sep; 287(39):32780-90. PubMed ID: 22846996 [TBL] [Abstract][Full Text] [Related]
2. Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin. Rhodes DA; Chen HC; Price AJ; Keeble AH; Davey MS; James LC; Eberl M; Trowsdale J J Immunol; 2015 Mar; 194(5):2390-8. PubMed ID: 25637025 [TBL] [Abstract][Full Text] [Related]
3. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. Harly C; Guillaume Y; Nedellec S; Peigné CM; Mönkkönen H; Mönkkönen J; Li J; Kuball J; Adams EJ; Netzer S; Déchanet-Merville J; Léger A; Herrmann T; Breathnach R; Olive D; Bonneville M; Scotet E Blood; 2012 Sep; 120(11):2269-79. PubMed ID: 22767497 [TBL] [Abstract][Full Text] [Related]
4. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells. Sandstrom A; Peigné CM; Léger A; Crooks JE; Konczak F; Gesnel MC; Breathnach R; Bonneville M; Scotet E; Adams EJ Immunity; 2014 Apr; 40(4):490-500. PubMed ID: 24703779 [TBL] [Abstract][Full Text] [Related]
5. Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation. Starick L; Riano F; Karunakaran MM; Kunzmann V; Li J; Kreiss M; Amslinger S; Scotet E; Olive D; De Libero G; Herrmann T Eur J Immunol; 2017 Jun; 47(6):982-992. PubMed ID: 28386905 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters. Rhodes DA; Chen HC; Williamson JC; Hill A; Yuan J; Smith S; Rhodes H; Trowsdale J; Lehner PJ; Herrmann T; Eberl M Front Immunol; 2018; 9():662. PubMed ID: 29670629 [TBL] [Abstract][Full Text] [Related]
7. Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells. Wang H; Henry O; Distefano MD; Wang YC; Räikkönen J; Mönkkönen J; Tanaka Y; Morita CT J Immunol; 2013 Aug; 191(3):1029-42. PubMed ID: 23833237 [TBL] [Abstract][Full Text] [Related]
8. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells. Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935 [TBL] [Abstract][Full Text] [Related]
9. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells. Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569 [TBL] [Abstract][Full Text] [Related]
10. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation. Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997 [TBL] [Abstract][Full Text] [Related]
11. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing. Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411 [TBL] [Abstract][Full Text] [Related]
12. BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against Gay L; Mezouar S; Cano C; Foucher E; Gabriac M; Fullana M; Madakamutil L; Mège JL; Olive D Front Immunol; 2022; 13():915244. PubMed ID: 35833118 [TBL] [Abstract][Full Text] [Related]
13. Analysis of macaque BTN3A genes and transcripts in the extended MHC: conserved orthologs of human γδ T cell modulators. de Groot N; Groen R; Orie V; Bruijnesteijn J; de Groot NG; Doxiadis GGM; Bontrop RE Immunogenetics; 2019 Sep; 71(8-9):545-559. PubMed ID: 31384962 [TBL] [Abstract][Full Text] [Related]
14. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation. Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636 [TBL] [Abstract][Full Text] [Related]
15. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing. Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T Nat Commun; 2023 Nov; 14(1):7617. PubMed ID: 37993425 [TBL] [Abstract][Full Text] [Related]
16. Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens. Moulin M; Alguacil J; Gu S; Mehtougui A; Adams EJ; Peyrottes S; Champagne E Cell Mol Life Sci; 2017 Dec; 74(23):4353-4367. PubMed ID: 28669030 [TBL] [Abstract][Full Text] [Related]
17. Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells. Boutin L; Scotet E Front Immunol; 2018; 9():828. PubMed ID: 29731756 [TBL] [Abstract][Full Text] [Related]
18. Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6. Riaño F; Karunakaran MM; Starick L; Li J; Scholz CJ; Kunzmann V; Olive D; Amslinger S; Herrmann T Eur J Immunol; 2014 Sep; 44(9):2571-6. PubMed ID: 24890657 [TBL] [Abstract][Full Text] [Related]